Preclinical data demonstrate that the proprietary coating does not elute and has been proven to be bactericidal.

The first patient is enrolled in ARISE II, an IDE research study to examine investigational MicroFat vs. saline injection to treat knee OA.

The Ensemble CMC joint replacement was developed as a minimally invasive treatment of thumb osteoarthritis.

The system adds ambulatory surgical center-ready flexibility for healthcare providers treating SI joint dysfunction.

The system is designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repair and high ankle sprains.

The device from NovApproach Spine supports the spectrum of anterior approaches with multi-insertion/multi-fixation technology.

Gamma4 is indicated for the treatment of fractures in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur.

GID BIO completed enrollment for the first of two pivotal Phase III studies to investigate the use of your own stromal vascular fraction cells to treat osteoarthritis of the knee.

SI joint fusion with PainTEQ’s LinQ SI Joint Stabilization System shows promise for treating patients with sacroiliac joint dysfunction.

The patent addresses RemeOs’ magnesium-calcium-zinc alloy composition and includes its use in the manufacturing of orthopedic implants.